Two case reports of severe myocarditis associated with the initiation of dolutegravir treatment in HIV patients

RATIONALE: The integrase inhibitor dolutegravir is now recommended as first-line treatment for HIV. A single case of myocarditis after treatment with dolutegravir was reported in the FLAMINGO trial. We present here 2 cases of severe myocarditis that occurred shortly after the initiation of dolutegra...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahlab-Guri, Keren, Asher, Ilan, Rosenberg-Bezalel, Shira, Elbirt, Daniel, Burke, Michael, Sthoeger, Zev M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4850
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134886/
https://www.ncbi.nlm.nih.gov/pubmed/27893693
http://dx.doi.org/10.1097/MD.0000000000005465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134886/
https://www.ncbi.nlm.nih.gov/pubmed/27893693
http://dx.doi.org/10.1097/MD.0000000000005465

Ejemplares similares